8:00 – 8:15 am

ACADEMIA/INDUSTRY/FDA/NIH ROUNDTABLE ON ENGINEERING THE FUTURE OF NEUROINTERVENTIONAL CARE-OBJECTIVES

Location: Metropolitan Galleries 1-3

Chairs:

Ajay K. Wakhloo, Tufts University School of Medicine, Boston, MA

Ricardo Hanel, Baptist Health, Jacksonville, FL

Raul G. Nogueira, University of Pittsburgh School of Medicine, Pittsburgh, PA

Introduction:Ajay K. Wakhloo, Tufts University School of Medicine, Boston, MA

8:15 – 9:15 am

SESSION 1: WHAT HAS ARISEN – TRANSLATING INNOVATION INTO INTERVENTION; UPDATES ON ANEURYSM, ICH, MMA, AND VENOUS INNOVATIONS

Chair: TBA

8:15 – 8:20
cSDH and MIDDLE MENINGEAL ARTERY EMBOLIZATION
Presentation by Peter Kan, UTMB, Galveston, TX

8:20 – 8:25
CEREBRAL VENOUS DISEASE
Presentation by Matthew Amans, UCSF, CA

8:25 – 8:30
ANEURYSMS
Presentation by Stavropoula Tjoumakaris, Thomas Jefferson University, Philadelphia, PA

 8:30 – 8:35
bAVM
Presentation by Edgar Samaniego, University of Iowa, Iowa City, IA

ICH
8:35 – 8:40
Presentation by TBA

REACH and MINUTE trial comparison
8:40 – 8:50
Presentation by Magdy Selim, Harvard Medical School, Boston, MA

8:50 – 9:15 ROUNDTABLE PANEL DISCUSSION

Panelists:
Jaime Raben, Director, Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices, FDA
Sara Thompson, Assistant Director, Neurointerventional Devices Team, FDA
Clemens Schirmer, Geisinger Commonwealth School of Medicine, Scranton, PA
Luis Savastano, University of California, San Francisco, CA
Adel Malek, Tufts University School of Medicine, Boston, MA
TBC

  9:15 – 11:30 am

SESSION 2: CEREBROVASCULATURE – WHAT IS SMALL AND WHAT IS LARGE IN THE WORLD OF NEUROVASCULAR INTERVENTION?

Location: Metropolitan Galleries 1-3

Chairs: Raul G. Nogueira, UPMC Stroke Institute, USA
Johana Fifi, Mount Sinai Health System, New York, NY

9:15 – 9:35
HOW DO WE DEFINE LVO, MeVo DiVo?
9:15 – 9:25 Presentation by David Liebeskind, UCLA, USA
9:25 – 9:40 Comments by Magdy Selim, Harvard Medical School, Boston, MA
Adnan Qureshi, University of Missouri School of Medicine, Columbia, MO

9:40 – 9:50
INTELLIGENT DATA COLLECTION AND PROCESSING
Presentation by Santiago Ortega-Gutiérrez, University of Iowa, Iowa City, IA

9:50 – 10:10
NET WATER UPTAKE (NWU)
9:50 – 10:00 Presentation by TBA
10:00 – 10:10 Comments by David Fiorella, Renaissance School of Medicine at Stonybrook University, New York, NY

10:10 – 10:30
WHY DID MeVo TRIAL FAIL
10:10 – 10:20 Presentation by Marc Ribo, Hospital Vall d’Hebron, Spain
10:20 – 10:30 Comments by TBA

10:30 – 10:50
FUTURE FOR MeVo TRIALS
10:30 – 10:40 Presentation by Raul Nogueira, University of Pittsburgh School of Medicine, Pittsburgh, PA
10:40 – 10:50 Comments by TBA

10:50 – 11:25
ROUNDTABLE PANEL DISCUSSION

Panelists:
William Ashley, Neurointerventional Devices Team, FDA
Leigh Anderson, Acute Stroke Devices Team, FDA
Eytan Raz, NYU Langone Health, New York, NY
TBC

 11:40 am –  12:40 pm

AI

Location: Metropolitan Galleries 1-3

Chair: Demetrius Lopes, Advocate Aurora Health, Chicago, IL

11:40 – 11:50
INTRODUCTION TO AI IN NEUROINTERVENTION
Presentation by Thomas Booth, King’s College London, UK

11:50 – 12:04
AUTOMATION IN NEUROINTERVENTION
Presentation by Ansaar Rai, Rockefeller Neurosciences Institute, Morgantown, WV and Matthew Gounis, UMass Chan Medical School, Worcester, MA

12:04 – 12:18
AI IN THE CATH LAB
Presentation by Demetrius Lopes, Advocate Aurora Health, Chicago, IL and Kenichi Kono, Showa University Fujigaoka Hospital, Japan

12:18 – 12:50
ROUNDTABLE PANEL DISCUSSION

Panelists:
Shahram Majidi, Mount Sinai Health System, New York, NY
Jan-Karl Burkhardt, University of Pennsylvania, Philadelphia, PA
FDA
NIH
TBC

  1:50 pm – 4:10 pm

SESSION 3: COMBINED ACCESS, AI + ROBOTICS INTEGRATION

Location: Metropolitan Galleries 1-3

Chairs: Ricardo Hanel, Baptist Health, Jacksonville, FL

1:50 – 2:10
COMBINED PRESENTATION REGULATORY PATH FOR ROBOTIC NEUROINTERVENTION: SHOULD IT BE DISEASE SPECIFIC?/ FDA PERSPECTIVE: REGULATIONS ON REMOTE THROMBECTOMY

1:50 – 2:05 Presentation by Naira Muradyan, Assistant Director, Acute Stroke Devices Team, FDA
Jaime Raben, Director, Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices, FDA
2:05 – 2:10 Comments by Fawaz Al- Mufti, Westchester Medical Center Health Network, Valhalla, NY

2:10 – 3:10
ROUNDTABLE PANEL DISCUSSION

Panelists:
Carlos Pena, Jacobs Institute, Buffalo, NY
Brian Hoh,  University of Florida, Gainesville, FL
Ferdinand Hui, The Queen’s Medical Center, University of Hawaii, HI
Dileep Yavagal, University of Miami School of Medicine, Miami, FL
Brian Jankowitz, JFK University Medical Center, Edison, NJ
Patrick Noonan, FDA
NIH

3:10 – 3:20
ROBOTICS FOR VASCULAR ACCESS
Presentation by Eric Peterson, University of Miami Miller School of Medicine, Miami, FL

3:20 – 3:40
DEBATE ROBOTIC SYSTEMS: DEVICE AGNOSTIC OR DEVICE SPECIFIC
3:20 – 3:30 DEVICE AGNOSTIC
Presentation by Vitor Pereira, University of Toronto and St Michael’s Hospital, Canada
3:30 – 3:40 DEVICE SPECIFIC
Presentation by Aquilla Turk, University of South Carolina, Greenville, SC

3:40 – 4:10
ROUNDTABLE PANEL DISCUSSION

Panelists:
Ramesh Grandhi, University of Utah, Salt Lake City, UT
Satoshi Tateshima, UCLA, Los Angeles, CA
Naira Muradyan, Assistant Director, Acute Stroke Devices Team, FDA
Jaime Raben, Director, Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices, FDA
NIH
TBC

4:35 – 6:00 pm

SESSION 4: AMBULATORY NEUROINTERVENTIONAL CARE: CLINICAL REALITY OR BUSINESS DISRUPTION?

Location: Metropolitan Galleries 1-3

Chair: Ajay K Wakhloo, Tufts University School of Medicine, Boston, MA

4:35 – 4:40
INTRODUCTION
Ajay K Wakhloo, Tufts University School of Medicine, Boston, MA

4:40 – 5:00
DEBATE: DOES AMBULATORY NEUROINTERVENTIONAL CARE MAKES SENSE?

4:40 – 4:50
YES
Presentation by Elad Levy, University at Buffalo, Buffalo, NY

4:50 – 5:00
NO
Presentation by TBA

5:00 – 5:10
AMBULATORY PATIENT CARE: HOSPITAL PERSPECTIVE
Presentation by TBA

5:10 – 5:20
AMBULATORY PATIENT CARE: INSURER PERSPECTIVE
Presentation by TBA

5:20 – 5:30
GLOBAL PERSPECTIVE ON AMBULATORY CARE FROM OTHER REGIONS
Presentation by Pedro Lylyk, University of Buenos Aires, Argentina

5:30 – 6:00
ROUNDTABLE PANEL DISCUSSION

Panelists:
David Altschul, Montefiore Medical Center, New York, NY
FDA
TBC